Viking Global Opportunities Parent GP LLC

10% owner at Roivant Sciences Ltd. · on record since Jun 26, 2023
10% owner at 4D Molecular Therapeutics, Inc. · on record since May 11, 2023
10% owner at Inhibrx Biosciences, Inc. · on record since Aug 30, 2023
10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
10% owner at BridgeBio Pharma, Inc. · on record since Jul 19, 2023
10% owner at LABRANCHE & CO INC · on record since Mar 20, 2024
10% owner at APi Group Corp · on record since Mar 7, 2024
10% owner at Glori Energy Inc. · on record since Jun 7, 2024
10% owner at TIC Solutions, Inc. · on record since Feb 14, 2025
10% owner at PROCEPT BioRobotics Corp · on record since Mar 22, 2022
10% owner at Amylyx Pharmaceuticals, Inc. · on record since Jan 13, 2022
10% owner at GENENTECH INC · on record since Mar 4, 2022
10% owner at Frazier Lifesciences Acquisition Corp · on record since Nov 25, 2022
10% owner at Rallybio Corp · on record since Nov 17, 2022

Insider trading activity of Viking Global Opportunities Parent GP LLC

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Inhibrx Biosciences, Inc.Listing unverified	Oct 9, 2025	Sell	-25,042	32.25 USD	$807.6K		SEC
Inhibrx Biosciences, Inc.Listing unverified	Oct 9, 2025	Sell	-308,643	32.25 USD	$10M		SEC
Inhibrx Biosciences, Inc.Listing unverified	Oct 9, 2025	Sell	-16,315	32.25 USD	$526.2K		SEC
Frazier Lifesciences Acquisition CorpListing unverified	Nov 25, 2022	Other	-2,459,880	—	n/a (No price was disclosed in the filing)		SEC
Frazier Lifesciences Acquisition CorpListing unverified	Nov 25, 2022	Other	-1,211,582	—	n/a (No price was disclosed in the filing)		SEC
Rallybio CorpListing on record	Nov 17, 2022	BuyD (derivative)	3,333,388	6.00 USD	$20M	First in 12mo	SEC
PROCEPT BioRobotics CorpListing on record	Mar 22, 2022	Sell	-101,795	29.90 USD	$3M		SEC
PROCEPT BioRobotics CorpListing on record	Mar 22, 2022	Sell	-1,147,205	29.90 USD	$34.3M		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Inhibrx Biosciences, Inc.Listing unverified	Oct 9, 2025	Sell	-25,042	32.25 USD	$807.6K		SEC
Inhibrx Biosciences, Inc.Listing unverified	Oct 9, 2025	Sell	-308,643	32.25 USD	$10M		SEC
Inhibrx Biosciences, Inc.Listing unverified	Oct 9, 2025	Sell	-16,315	32.25 USD	$526.2K		SEC
Frazier Lifesciences Acquisition CorpListing unverified	Nov 25, 2022	Other	-2,459,880	—	n/a (No price was disclosed in the filing)		SEC
Frazier Lifesciences Acquisition CorpListing unverified	Nov 25, 2022	Other	-1,211,582	—	n/a (No price was disclosed in the filing)		SEC
Rallybio CorpListing on record	Nov 17, 2022	BuyD (derivative)	3,333,388	6.00 USD	$20M	First in 12mo	SEC
PROCEPT BioRobotics CorpListing on record	Mar 22, 2022	Sell	-101,795	29.90 USD	$3M		SEC
PROCEPT BioRobotics CorpListing on record	Mar 22, 2022	Sell	-1,147,205	29.90 USD	$34.3M		SEC